Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Environmental Exposure | 23 | 2024 | 4533 | 2.810 |
Why?
|
Nutrition Surveys | 28 | 2024 | 1734 | 2.700 |
Why?
|
Drug Repositioning | 6 | 2018 | 244 | 2.520 |
Why?
|
Metagenomics | 5 | 2023 | 476 | 1.780 |
Why?
|
Computational Biology | 13 | 2024 | 3546 | 1.670 |
Why?
|
Disease | 6 | 2019 | 673 | 1.350 |
Why?
|
Environmental Pollutants | 8 | 2024 | 1290 | 1.330 |
Why?
|
Metagenome | 4 | 2023 | 465 | 1.330 |
Why?
|
Diabetes Mellitus, Type 2 | 15 | 2024 | 12242 | 1.150 |
Why?
|
Endocrine Disruptors | 2 | 2021 | 264 | 1.080 |
Why?
|
Environmental Health | 6 | 2021 | 295 | 1.070 |
Why?
|
Toxicogenetics | 3 | 2016 | 19 | 0.990 |
Why?
|
Prediabetic State | 2 | 2021 | 548 | 0.970 |
Why?
|
Databases, Factual | 11 | 2019 | 8081 | 0.910 |
Why?
|
Epidemiologic Research Design | 3 | 2020 | 368 | 0.900 |
Why?
|
Biological Specimen Banks | 3 | 2024 | 783 | 0.900 |
Why?
|
Software | 10 | 2024 | 4463 | 0.880 |
Why?
|
Government | 1 | 2024 | 162 | 0.860 |
Why?
|
Extreme Heat | 1 | 2023 | 60 | 0.820 |
Why?
|
Genetic Predisposition to Disease | 13 | 2024 | 18048 | 0.700 |
Why?
|
Models, Statistical | 6 | 2021 | 5103 | 0.700 |
Why?
|
Genome, Human | 5 | 2018 | 4453 | 0.700 |
Why?
|
Blood Glucose | 6 | 2024 | 6429 | 0.670 |
Why?
|
Semen Analysis | 2 | 2018 | 236 | 0.660 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12774 | 0.660 |
Why?
|
Genetic Association Studies | 7 | 2024 | 2742 | 0.640 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2024 | 3246 | 0.610 |
Why?
|
Disease Transmission, Infectious | 1 | 2024 | 562 | 0.600 |
Why?
|
Genetic Variation | 10 | 2019 | 6610 | 0.580 |
Why?
|
Phenotype | 16 | 2024 | 16712 | 0.580 |
Why?
|
Medical Subject Headings | 1 | 2017 | 16 | 0.570 |
Why?
|
Biostatistics | 1 | 2019 | 165 | 0.570 |
Why?
|
Humans | 131 | 2024 | 768451 | 0.560 |
Why?
|
Lyme Disease | 1 | 2023 | 631 | 0.550 |
Why?
|
Semen | 1 | 2018 | 349 | 0.520 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 472 | 0.520 |
Why?
|
Phthalic Acids | 1 | 2021 | 483 | 0.510 |
Why?
|
Bupropion | 1 | 2018 | 304 | 0.510 |
Why?
|
Fatty Liver | 1 | 2022 | 807 | 0.510 |
Why?
|
Fertilization | 1 | 2016 | 198 | 0.510 |
Why?
|
Fertility | 2 | 2018 | 772 | 0.500 |
Why?
|
Risk Factors | 31 | 2024 | 74915 | 0.500 |
Why?
|
Sperm Motility | 1 | 2016 | 266 | 0.490 |
Why?
|
Environment | 5 | 2020 | 1126 | 0.490 |
Why?
|
Body Height | 1 | 2021 | 1568 | 0.490 |
Why?
|
Epidemiologic Methods | 2 | 2021 | 1337 | 0.490 |
Why?
|
Epidemiologic Studies | 3 | 2015 | 681 | 0.470 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9507 | 0.470 |
Why?
|
Bacteria | 3 | 2022 | 2226 | 0.470 |
Why?
|
Biomedical Research | 2 | 2022 | 3463 | 0.450 |
Why?
|
Mortality | 3 | 2024 | 2917 | 0.450 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 1036 | 0.440 |
Why?
|
Estrogens, Non-Steroidal | 1 | 2013 | 52 | 0.440 |
Why?
|
Cholesterol | 2 | 2020 | 2910 | 0.430 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5887 | 0.430 |
Why?
|
Models, Theoretical | 6 | 2024 | 3590 | 0.420 |
Why?
|
Hyperglycemia | 2 | 2021 | 1389 | 0.410 |
Why?
|
Data Interpretation, Statistical | 3 | 2024 | 2705 | 0.410 |
Why?
|
Phenols | 2 | 2013 | 520 | 0.400 |
Why?
|
Reproduction | 1 | 2017 | 646 | 0.400 |
Why?
|
Spermatozoa | 1 | 2016 | 631 | 0.400 |
Why?
|
Blood | 1 | 2015 | 597 | 0.400 |
Why?
|
Breast Feeding | 1 | 2020 | 1365 | 0.380 |
Why?
|
Genetics, Population | 3 | 2013 | 946 | 0.370 |
Why?
|
Cause of Death | 2 | 2024 | 3727 | 0.370 |
Why?
|
Fasting | 3 | 2024 | 1608 | 0.370 |
Why?
|
Insulin Resistance | 4 | 2022 | 3974 | 0.360 |
Why?
|
Aging | 3 | 2020 | 8761 | 0.360 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.360 |
Why?
|
Computer Simulation | 6 | 2024 | 6278 | 0.350 |
Why?
|
Predictive Value of Tests | 3 | 2024 | 15460 | 0.350 |
Why?
|
Exercise | 2 | 2024 | 5940 | 0.350 |
Why?
|
Communicable Diseases | 1 | 2018 | 875 | 0.340 |
Why?
|
Environmental Monitoring | 4 | 2017 | 1464 | 0.330 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1465 | 0.330 |
Why?
|
Dementia | 1 | 2024 | 2723 | 0.330 |
Why?
|
Benzhydryl Compounds | 2 | 2013 | 939 | 0.330 |
Why?
|
Male | 53 | 2024 | 364781 | 0.330 |
Why?
|
Prescription Drugs | 1 | 2016 | 634 | 0.320 |
Why?
|
Risk Assessment | 9 | 2024 | 24311 | 0.320 |
Why?
|
Socioeconomic Factors | 4 | 2023 | 7863 | 0.300 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4249 | 0.300 |
Why?
|
Adult | 39 | 2024 | 223542 | 0.300 |
Why?
|
Sexual Behavior | 1 | 2018 | 2200 | 0.300 |
Why?
|
Female | 50 | 2024 | 396943 | 0.290 |
Why?
|
United States | 20 | 2024 | 73121 | 0.290 |
Why?
|
Pharmaceutical Preparations | 1 | 2016 | 1089 | 0.290 |
Why?
|
Body Mass Index | 7 | 2022 | 13030 | 0.280 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2659 | 0.280 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3794 | 0.280 |
Why?
|
Occupational Exposure | 1 | 2017 | 1818 | 0.270 |
Why?
|
Middle Aged | 32 | 2024 | 223418 | 0.270 |
Why?
|
Maternal Exposure | 1 | 2013 | 1078 | 0.270 |
Why?
|
Cohort Studies | 13 | 2023 | 41797 | 0.260 |
Why?
|
Income | 1 | 2015 | 1878 | 0.260 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7471 | 0.250 |
Why?
|
Public Health | 3 | 2017 | 2693 | 0.240 |
Why?
|
Carotenoids | 3 | 2013 | 621 | 0.240 |
Why?
|
Cross-Sectional Studies | 13 | 2024 | 26351 | 0.240 |
Why?
|
Coronary Disease | 1 | 2019 | 5926 | 0.240 |
Why?
|
Nutrition Policy | 2 | 2019 | 467 | 0.230 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4298 | 0.230 |
Why?
|
Prevalence | 7 | 2024 | 15880 | 0.220 |
Why?
|
Obesity | 4 | 2023 | 13065 | 0.220 |
Why?
|
Multivariate Analysis | 5 | 2018 | 12096 | 0.220 |
Why?
|
Reference Values | 3 | 2021 | 4941 | 0.220 |
Why?
|
Young Adult | 17 | 2024 | 60045 | 0.220 |
Why?
|
Motor Activity | 1 | 2013 | 2722 | 0.220 |
Why?
|
Smoking | 3 | 2023 | 9099 | 0.220 |
Why?
|
Blood Pressure | 2 | 2016 | 8538 | 0.210 |
Why?
|
Delphi Technique | 2 | 2024 | 879 | 0.210 |
Why?
|
Cluster Analysis | 4 | 2021 | 2731 | 0.210 |
Why?
|
Diabetic Nephropathies | 2 | 2024 | 975 | 0.210 |
Why?
|
Climate | 1 | 2023 | 148 | 0.200 |
Why?
|
Linear Models | 3 | 2018 | 5880 | 0.200 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11206 | 0.200 |
Why?
|
Chronic Disease | 3 | 2023 | 9382 | 0.200 |
Why?
|
Weather | 1 | 2023 | 232 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2021 | 16029 | 0.200 |
Why?
|
Health Surveys | 3 | 2020 | 4056 | 0.190 |
Why?
|
Health Status | 1 | 2015 | 4096 | 0.190 |
Why?
|
Cardiac Imaging Techniques | 1 | 2024 | 281 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15638 | 0.190 |
Why?
|
Premature Birth | 1 | 2013 | 1816 | 0.190 |
Why?
|
Sample Size | 3 | 2021 | 851 | 0.190 |
Why?
|
Algorithms | 8 | 2024 | 14158 | 0.180 |
Why?
|
Netherlands | 3 | 2021 | 2274 | 0.180 |
Why?
|
Neoplasms | 6 | 2022 | 22386 | 0.180 |
Why?
|
Eligibility Determination | 1 | 2024 | 420 | 0.180 |
Why?
|
Lipids | 1 | 2012 | 3346 | 0.180 |
Why?
|
Waist Circumference | 2 | 2022 | 935 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6966 | 0.180 |
Why?
|
Asthma | 1 | 2019 | 6274 | 0.170 |
Why?
|
Parabens | 1 | 2021 | 117 | 0.170 |
Why?
|
Databases, Genetic | 3 | 2018 | 1750 | 0.170 |
Why?
|
Pharmaceutical Services | 1 | 2021 | 143 | 0.170 |
Why?
|
Receptors, GABA-A | 1 | 2024 | 626 | 0.170 |
Why?
|
Drinking Behavior | 1 | 2020 | 103 | 0.170 |
Why?
|
Aged | 18 | 2024 | 171520 | 0.170 |
Why?
|
Infant | 9 | 2024 | 36497 | 0.170 |
Why?
|
Pharmacoepidemiology | 1 | 2023 | 352 | 0.170 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 177 | 0.160 |
Why?
|
Micrognathism | 1 | 2019 | 64 | 0.160 |
Why?
|
Meat Products | 1 | 2019 | 96 | 0.160 |
Why?
|
Psychopathology | 1 | 2022 | 435 | 0.160 |
Why?
|
Respiratory Function Tests | 1 | 2024 | 1697 | 0.160 |
Why?
|
California | 1 | 2023 | 1444 | 0.160 |
Why?
|
Micronutrients | 2 | 2012 | 390 | 0.160 |
Why?
|
Kidney Failure, Chronic | 2 | 2024 | 2489 | 0.160 |
Why?
|
Coloboma | 1 | 2019 | 60 | 0.160 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 167 | 0.160 |
Why?
|
Trypsinogen | 1 | 2018 | 84 | 0.160 |
Why?
|
Vibration | 1 | 2021 | 335 | 0.160 |
Why?
|
Sex Factors | 3 | 2020 | 10647 | 0.160 |
Why?
|
Family Characteristics | 1 | 2024 | 1002 | 0.160 |
Why?
|
Genetic Testing | 2 | 2023 | 3586 | 0.160 |
Why?
|
Programming, Linear | 1 | 2018 | 8 | 0.150 |
Why?
|
Air Pollution | 2 | 2023 | 2364 | 0.150 |
Why?
|
Age Factors | 3 | 2024 | 18478 | 0.150 |
Why?
|
Hand Deformities, Congenital | 1 | 2019 | 175 | 0.150 |
Why?
|
Life Style | 3 | 2020 | 3929 | 0.150 |
Why?
|
Air Pollutants | 2 | 2023 | 2905 | 0.150 |
Why?
|
Delayed Graft Function | 1 | 2018 | 53 | 0.150 |
Why?
|
Research Design | 4 | 2023 | 6217 | 0.150 |
Why?
|
Geography | 1 | 2020 | 654 | 0.150 |
Why?
|
Trypsin | 1 | 2018 | 494 | 0.150 |
Why?
|
Adolescent | 13 | 2024 | 89168 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2022 | 2444 | 0.150 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 738 | 0.150 |
Why?
|
Prospective Studies | 8 | 2021 | 54914 | 0.150 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1051 | 0.150 |
Why?
|
Heart Failure | 1 | 2022 | 11857 | 0.140 |
Why?
|
Validation Studies as Topic | 1 | 2018 | 162 | 0.140 |
Why?
|
Nervous System Malformations | 1 | 2019 | 244 | 0.140 |
Why?
|
Twins | 1 | 2019 | 340 | 0.140 |
Why?
|
Cadmium | 2 | 2020 | 216 | 0.140 |
Why?
|
Asparaginase | 1 | 2018 | 240 | 0.140 |
Why?
|
MEDLINE | 1 | 2017 | 119 | 0.140 |
Why?
|
Mifepristone | 1 | 2018 | 151 | 0.140 |
Why?
|
Embolism, Fat | 1 | 2017 | 46 | 0.140 |
Why?
|
RNA Splicing | 1 | 2021 | 906 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1189 | 0.140 |
Why?
|
Self Report | 2 | 2020 | 3771 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 510 | 0.140 |
Why?
|
Species Specificity | 1 | 2021 | 2422 | 0.140 |
Why?
|
T-Box Domain Proteins | 1 | 2019 | 473 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2237 | 0.140 |
Why?
|
Alleles | 4 | 2024 | 6890 | 0.140 |
Why?
|
Specialization | 1 | 2021 | 782 | 0.140 |
Why?
|
Epilepsy | 2 | 2024 | 3324 | 0.130 |
Why?
|
Donor Selection | 1 | 2018 | 240 | 0.130 |
Why?
|
Fumarates | 1 | 2017 | 132 | 0.130 |
Why?
|
Hypertension | 1 | 2016 | 8611 | 0.130 |
Why?
|
Child, Preschool | 9 | 2024 | 42623 | 0.130 |
Why?
|
Diet | 4 | 2019 | 8098 | 0.130 |
Why?
|
Sperm Count | 1 | 2016 | 229 | 0.130 |
Why?
|
Thyroid Nodule | 1 | 2023 | 766 | 0.130 |
Why?
|
Pandemics | 3 | 2024 | 8753 | 0.130 |
Why?
|
Coffee | 1 | 2020 | 598 | 0.130 |
Why?
|
Insurance, Health | 2 | 2019 | 2513 | 0.120 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 604 | 0.120 |
Why?
|
Body Dysmorphic Disorders | 1 | 2019 | 243 | 0.120 |
Why?
|
Pregnancy, Ectopic | 1 | 2017 | 146 | 0.120 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1244 | 0.120 |
Why?
|
Population Groups | 1 | 2016 | 208 | 0.120 |
Why?
|
Feces | 1 | 2022 | 1515 | 0.120 |
Why?
|
Oligonucleotide Probes | 1 | 2015 | 417 | 0.120 |
Why?
|
Pancreas | 1 | 2022 | 1703 | 0.120 |
Why?
|
Waist-Hip Ratio | 1 | 2016 | 520 | 0.120 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2015 | 25 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1299 | 0.120 |
Why?
|
Fibrosis | 1 | 2022 | 2076 | 0.120 |
Why?
|
Australia | 3 | 2024 | 1264 | 0.120 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 792 | 0.120 |
Why?
|
Renal Dialysis | 1 | 2024 | 1802 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2028 | 0.120 |
Why?
|
Neck | 1 | 2019 | 736 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3207 | 0.110 |
Why?
|
Amides | 1 | 2017 | 452 | 0.110 |
Why?
|
beta Catenin | 1 | 2019 | 1048 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 458 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2204 | 0.110 |
Why?
|
Selection, Genetic | 1 | 2018 | 877 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1353 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2846 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 375 | 0.110 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12561 | 0.110 |
Why?
|
Triclosan | 1 | 2013 | 58 | 0.110 |
Why?
|
Face | 1 | 2019 | 1031 | 0.110 |
Why?
|
Nutrition Assessment | 1 | 2016 | 740 | 0.110 |
Why?
|
Homosexuality, Female | 1 | 2015 | 171 | 0.110 |
Why?
|
India | 1 | 2020 | 2323 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 749 | 0.110 |
Why?
|
Models, Genetic | 3 | 2017 | 3442 | 0.110 |
Why?
|
Bisexuality | 1 | 2015 | 294 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1195 | 0.100 |
Why?
|
Colorectal Neoplasms | 3 | 2022 | 6978 | 0.100 |
Why?
|
Child | 11 | 2024 | 80863 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1339 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2226 | 0.100 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2021 | 2203 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2024 | 26395 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2792 | 0.100 |
Why?
|
Pesticides | 2 | 2018 | 299 | 0.100 |
Why?
|
Ecosystem | 1 | 2016 | 494 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14766 | 0.100 |
Why?
|
Statistics as Topic | 1 | 2018 | 2362 | 0.100 |
Why?
|
Abnormalities, Multiple | 1 | 2019 | 1424 | 0.100 |
Why?
|
Virulence | 1 | 2016 | 1303 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2117 | 0.100 |
Why?
|
Cerebellum | 1 | 2019 | 1515 | 0.100 |
Why?
|
Haplotypes | 1 | 2018 | 2725 | 0.100 |
Why?
|
RNA | 1 | 2021 | 2727 | 0.100 |
Why?
|
Pancreatitis | 1 | 2018 | 1087 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1950 | 0.090 |
Why?
|
HIV Infections | 1 | 2018 | 17564 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2015 | 489 | 0.090 |
Why?
|
Retrospective Studies | 9 | 2024 | 81834 | 0.090 |
Why?
|
Pregnancy | 4 | 2018 | 30179 | 0.090 |
Why?
|
Nutritional Status | 3 | 2017 | 1623 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20231 | 0.090 |
Why?
|
Vitamin E | 1 | 2015 | 873 | 0.090 |
Why?
|
gamma-Tocopherol | 1 | 2010 | 30 | 0.090 |
Why?
|
Electronic Health Records | 3 | 2023 | 4877 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2019 | 1516 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2260 | 0.090 |
Why?
|
Incidence | 2 | 2021 | 21552 | 0.090 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11930 | 0.090 |
Why?
|
Emigration and Immigration | 1 | 2013 | 405 | 0.090 |
Why?
|
Genotype | 4 | 2024 | 13047 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2103 | 0.090 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 445 | 0.090 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 983 | 0.090 |
Why?
|
Prognosis | 4 | 2024 | 30028 | 0.080 |
Why?
|
Medication Adherence | 1 | 2021 | 2190 | 0.080 |
Why?
|
Gene Frequency | 2 | 2016 | 3615 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3253 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1557 | 0.080 |
Why?
|
Proteins | 1 | 2024 | 6008 | 0.080 |
Why?
|
Hazardous Substances | 1 | 2010 | 153 | 0.080 |
Why?
|
Genomics | 3 | 2022 | 5909 | 0.080 |
Why?
|
Glucose | 1 | 2021 | 4355 | 0.080 |
Why?
|
Glioma | 1 | 2024 | 3523 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9642 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2030 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2377 | 0.080 |
Why?
|
Kidney Calculi | 1 | 2013 | 469 | 0.080 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 236 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4630 | 0.080 |
Why?
|
Aged, 80 and over | 3 | 2024 | 59680 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3271 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5096 | 0.070 |
Why?
|
Dietary Fats | 1 | 2015 | 2003 | 0.070 |
Why?
|
Fatty Acids | 1 | 2015 | 1818 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2023 | 2358 | 0.070 |
Why?
|
Critical Illness | 1 | 2020 | 2754 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3440 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13708 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3245 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1539 | 0.070 |
Why?
|
Potassium, Dietary | 2 | 2020 | 103 | 0.070 |
Why?
|
Feeding Behavior | 2 | 2015 | 3202 | 0.070 |
Why?
|
Adiposity | 1 | 2016 | 1888 | 0.070 |
Why?
|
Liver | 1 | 2022 | 7575 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3197 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 1820 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1382 | 0.060 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2005 | 53 | 0.060 |
Why?
|
Health Promotion | 1 | 2017 | 2215 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2022 | 9066 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 3111 | 0.060 |
Why?
|
Graft Rejection | 1 | 2018 | 4505 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3854 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2834 | 0.060 |
Why?
|
Chorioallantoic Membrane | 1 | 2005 | 50 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3329 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 776 | 0.060 |
Why?
|
Veterans Disability Claims | 1 | 2024 | 24 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10358 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2465 | 0.060 |
Why?
|
Gene Expression | 1 | 2017 | 7605 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11515 | 0.050 |
Why?
|
Medicaid | 1 | 2017 | 2843 | 0.050 |
Why?
|
Mutation | 4 | 2021 | 30243 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2018 | 4285 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1949 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2024 | 9182 | 0.050 |
Why?
|
Spin Labels | 1 | 2024 | 339 | 0.050 |
Why?
|
Cholesterol, LDL | 1 | 2012 | 2396 | 0.050 |
Why?
|
Odds Ratio | 3 | 2024 | 9687 | 0.050 |
Why?
|
Family | 2 | 2015 | 3208 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9791 | 0.050 |
Why?
|
User-Computer Interface | 1 | 2008 | 1397 | 0.050 |
Why?
|
Databases, Protein | 1 | 2024 | 387 | 0.050 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4906 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8721 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2008 | 1514 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3237 | 0.050 |
Why?
|
Spirometry | 1 | 2024 | 928 | 0.050 |
Why?
|
Chemokine CCL22 | 1 | 2020 | 27 | 0.050 |
Why?
|
Clinical Chemistry Tests | 1 | 2020 | 59 | 0.040 |
Why?
|
Financing, Government | 1 | 2024 | 473 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 240 | 0.040 |
Why?
|
gamma-Glutamyltransferase | 1 | 2020 | 144 | 0.040 |
Why?
|
Blindness | 1 | 2024 | 588 | 0.040 |
Why?
|
Ethics, Research | 1 | 2021 | 177 | 0.040 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2020 | 85 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4340 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2020 | 235 | 0.040 |
Why?
|
American Heart Association | 1 | 2024 | 1049 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 2019 | 114 | 0.040 |
Why?
|
Conflict of Interest | 1 | 2024 | 556 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 199 | 0.040 |
Why?
|
Perfusion | 1 | 2024 | 1402 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8635 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5532 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
Computer Communication Networks | 1 | 2020 | 295 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 750 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15965 | 0.040 |
Why?
|
Muscle Spasticity | 1 | 2019 | 158 | 0.040 |
Why?
|
Bilirubin | 1 | 2020 | 439 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36840 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 712 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2023 | 798 | 0.040 |
Why?
|
Probability | 1 | 2023 | 2483 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2005 | 1369 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 865 | 0.040 |
Why?
|
Triolein | 1 | 2017 | 9 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1077 | 0.040 |
Why?
|
Serum Albumin | 1 | 2020 | 676 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2024 | 1839 | 0.030 |
Why?
|
National Health Programs | 1 | 2020 | 442 | 0.030 |
Why?
|
Mouth | 1 | 2019 | 383 | 0.030 |
Why?
|
Vehicle Emissions | 1 | 2021 | 656 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1604 | 0.030 |
Why?
|
Logistic Models | 2 | 2024 | 13324 | 0.030 |
Why?
|
Biodiversity | 1 | 2019 | 346 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2017 | 223 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1734 | 0.030 |
Why?
|
Magnesium | 1 | 2020 | 816 | 0.030 |
Why?
|
Multigene Family | 1 | 2019 | 1081 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 758 | 0.030 |
Why?
|
Occupational Diseases | 1 | 2024 | 1494 | 0.030 |
Why?
|
Caffeine | 1 | 2020 | 702 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5442 | 0.030 |
Why?
|
Microcephaly | 1 | 2019 | 426 | 0.030 |
Why?
|
Brain Death | 1 | 2018 | 360 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1915 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2024 | 1310 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2016 | 21156 | 0.030 |
Why?
|
Lead | 1 | 2020 | 880 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2019 | 1136 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1926 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2024 | 2737 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2039 | 0.030 |
Why?
|
Schools | 1 | 2022 | 1496 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4041 | 0.030 |
Why?
|
Diet Records | 1 | 2015 | 427 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 2000 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 840 | 0.030 |
Why?
|
Folic Acid | 1 | 2020 | 1336 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 1009 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3439 | 0.030 |
Why?
|
Human Genome Project | 1 | 2013 | 202 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4534 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2022 | 2119 | 0.020 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2013 | 87 | 0.020 |
Why?
|
Vitiligo | 1 | 2013 | 100 | 0.020 |
Why?
|
Peptides | 1 | 2024 | 4368 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.020 |
Why?
|
Vitamins | 1 | 2020 | 1638 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2020 | 2483 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4120 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2881 | 0.020 |
Why?
|
Contrast Media | 1 | 2024 | 5336 | 0.020 |
Why?
|
Alopecia Areata | 1 | 2013 | 130 | 0.020 |
Why?
|
Vitamin B Complex | 1 | 2012 | 299 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9505 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1725 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13589 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1840 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2015 | 727 | 0.020 |
Why?
|
Particulate Matter | 1 | 2021 | 2614 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10601 | 0.020 |
Why?
|
Ultrasonography | 1 | 2023 | 5995 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1898 | 0.020 |
Why?
|
Scleroderma, Systemic | 1 | 2013 | 349 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5308 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 2012 | 427 | 0.020 |
Why?
|
Aspirin | 1 | 2020 | 3139 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1605 | 0.020 |
Why?
|
Minority Groups | 1 | 2015 | 1215 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13452 | 0.020 |
Why?
|
Graft Survival | 1 | 2018 | 3890 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12875 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7451 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4545 | 0.020 |
Why?
|
Registries | 1 | 2023 | 8373 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6353 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4780 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8201 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11138 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3665 | 0.020 |
Why?
|
Energy Intake | 1 | 2012 | 2141 | 0.010 |
Why?
|
Forecasting | 1 | 2014 | 2950 | 0.010 |
Why?
|
Chick Embryo | 1 | 2005 | 978 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 4049 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23638 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 17149 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2013 | 1930 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23839 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2254 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2013 | 2173 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2826 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4052 | 0.010 |
Why?
|
Animals | 3 | 2019 | 169418 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6606 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40271 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18388 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5767 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39430 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2465 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2018 | 15880 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12428 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12813 | 0.010 |
Why?
|